Skip to search boxSkip to navigationSkip to main content

microRNA 1307 is a potential target for SARS-CoV-2 infection: an in vitro model

  • Elif Damla Arisan
    ,
  • Alwyn Dart
    ,
  • Guy Grant
    ,
  • Andrew Dalby
    ,
  • Derya Dilek Kancagi
    ,
  • Raife Dilek Turan
  • Gebze Technical University
    ,
  • City St George's, University of London
    ,
  • University of Westminster
    ,
  • Acibadem Labcell Cellular Therapy Laboratory
    ,
  • Yeditepe University
Research Output: Contribution to journal Article Peer-review

Open access

Abstract

microRNAs (miRs) are proposed as critical molecular targets in SARS-CoV-2 infection. Our recent in silico studies identified seven SARS-CoV-2 specific miR-like sequences, which are highly conserved with humans, including miR-1307-3p, with critical roles in COVID-19. In this current study, Vero cells were infected with SARS-CoV-2, and miR expression profiles were thereafter confirmed by qRT-PCR. miR-1307-3p was the most highly expressed miR in the infected cells; we, therefore, transiently inhibited its expression in both infected and uninfected cells. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cell proliferation assay assessed cell viability following SARS-CoV-2 infection, identifying that miR-1307 expression is inversely correlated with cell viability. Lastly, changes in miR-1307-dependent pathways were analyzed through a detailed miRNOME and associated in silico analysis. In addition to our previously identified miRs, including miR-1307-3p, the upregulation of miR-193a-5p, miR-5100, and miR-23a-5p and downregulation of miR-130b-5p, miR34a-5p, miR-505-3p, miR181a-2-3p, miR-1271-5p, miR-598-3p, miR-34c-3p, and miR-129-5p were also established in Vero cells related to general lung disease-related genes following SARS-CoV-2 infection. Targeted anti-miR-1307-3p treatment rescued cell viability in infection when compared to SARS CoV-2 mediated cell cytotoxicity only. We furthermore identified by in silico analysis that miR-1307-3p is conserved in all SARS-CoV-2 sequences/strains, except in the BA.2 variant, possibly contributing to the lower disease severity of this variant, which warrants further investigation. Small RNA seq analysis was next used to evaluate alterations in the miRNOME, following miR-1307-3p manipulation, identifying critical pathobiological pathways linked to SARS-CoV-2 infection-mediated upregulation of this miR. On the basis of our findings, miRNAs like miR-1307-3p play a critical role in SARS-CoV-2 infection, including via effects on disease progression and severity.

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 38003-38014 (12 pages)

Journal (Volume, Issue Number)

ACS Omega (Volume 7, Issue 42)

Publication milestones

  • Accepted/In press - 30/09/2022
  • Published - 11/10/2022

Publication status

Published - 11/10/2022

Publication IDs

  • handle.net: 10547/625554
  • Scopus: 85140605564
  • PubMed: 36275122

Access to documents

Publication metrics

Metrics

Download statistics
Download count
3